{"table": "Design", "nct_id": "NCT00387465", "fields": {"Route_Admin": {"value": "sc; oral", "evidence": "subcutaneously (SC) | orally (PO)"}, "Treat_Duration": {"value": "every 28 days", "evidence": "Treatment repeats every 28 days in the absence of disease progression or unacceptable toxicity"}, "Add_On_Treat": {"value": "yes", "evidence": "Azacitidine and entinostat | Giving azacitidine together with entinostat"}, "Adherence_Treat": {"value": "", "evidence": ""}, "Enroll_Duration_Plan": {"value": "", "evidence": ""}, "FU_Duration_Plan": {"value": "", "evidence": ""}}, "batch_index": 1, "batch_total": 2}
{"table": "Design", "nct_id": "NCT00387465", "fields": {"Central_Lab": {"value": "", "evidence": ""}, "Run_in": {"value": "", "evidence": ""}, "GCP_Compliance": {"value": "", "evidence": ""}, "Data_Cutoff_Date": {"value": "", "evidence": ""}}, "batch_index": 2, "batch_total": 2}
